Obesity and cardiovascular disease: revisiting an old relationship

C Koliaki, S Liatis, A Kokkinos - Metabolism, 2019 - Elsevier
A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of
cardiovascular diseases (CVD) including coronary heart disease, heart failure …

Obesity phenotypes and their paradoxical association with cardiovascular diseases

A Vecchié, F Dallegri, F Carbone… - European journal of …, 2018 - Elsevier
The pro-inflammatory state of the visceral adipose tissue (VAT) is supposed to accelerate
cardiovascular (CV) and metabolic diseases in obese subjects. Some studies have recently …

Obesity paradox: fact or fiction?

S Simati, A Kokkinos, M Dalamaga… - Current Obesity …, 2023 - Springer
Abstract Purpose of Review Obesity is related to several comorbidities such as type 2
diabetes mellitus, cardiovascular disease, heart failure, and various types of cancers. While …

[HTML][HTML] Obesity paradox does exist

V Hainer, I Aldhoon-Hainerová - Diabetes care, 2013 - ncbi.nlm.nih.gov
Adipose tissue has been shown to be a pivotal organ in the aging process and in the
determination of life span. Owing to the rising prevalence of obesity, especially at younger …

Obesity and cardiovascular disease: friend or foe?

SH Kim, JP Després, KK Koh - European heart journal, 2016 - academic.oup.com
Obesity is currently one of the greatest public health issues worldwide. However, despite its
known deleterious effects on the cardiovascular system and its association with numerous …

Mechanisms of heart failure in obesity

IA Ebong, DC Goff Jr, CJ Rodriguez, H Chen… - Obesity research & …, 2014 - Elsevier
Heart failure is a leading cause of morbidity and mortality and its prevalence continues to
rise. Because obesity has been linked with heart failure, the increasing prevalence of …

The obesity paradox and heart failure: a systematic review of a decade of evidence

EA Oga, OR Eseyin - Journal of obesity, 2016 - Wiley Online Library
There is scientific consensus that obesity increases the risk of cardiovascular diseases,
including heart failure. However, among persons who already have heart failure, outcomes …

Anti-inflammatory effects of melatonin in obesity and hypertension

NJ Prado, L Ferder, W Manucha, ER Diez - Current hypertension reports, 2018 - Springer
Abstract Purpose of Review Here, we review the known relations between hypertension and
obesity to inflammation and postulate the endogenous protective effect of melatonin and its …

[PDF][PDF] Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний (национальные клинические рекомендации)

ОМ Драпкина, ЮМ Лопатин, ВИ Петров, ОН Ткачева… - 2017 - volgmed.ru
Основной целью национальных междисциплинарных рекомендаций является
внедрение в клиническую практику ключевых подходов к профилактике, диагностике и …

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial

A Olivier, B Pitt, N Girerd, Z Lamiral… - European journal of …, 2017 - Wiley Online Library
Aims An excessive production of aldosterone influences outcome in patients with heart
failure (HF) and in obese patients. Findings from laboratory studies suggest that chronic …